Short answer · Medically reviewed summary · Last updated: 2026-05-08
Primary Hyperoxaluria is a group of rare, inherited metabolic disorders characterized by the overproduction of oxalate, typically referred to by the abbreviation PH. While the condition is most commonly known as Primary Hyperoxaluria, it is clinically categorized into three distinct types (PH1, PH2, and PH3) based on the specific enzyme deficiency involved. What are the common synonyms and historical names for Primary Hyperoxaluria? In medical literature, Primary Hyperoxaluria is sometimes referred to as primary hyperoxalosis or oxalate nephropathy, though the latter is often a descriptive term for the kidney damage caused by the disease rather than the genetic condition itself.
Primary Hyperoxaluria synonyms
Other names for Primary Hyperoxaluria: synonyms, acronyms and related terms used by doctors and patients.
Primary Hyperoxaluria is a group of rare, inherited metabolic disorders characterized by the overproduction of oxalate, typically referred to by the abbreviation PH. While the condition is most commonly known as Primary Hyperoxaluria, it is clinically categorized into three distinct types (PH1, PH2, and PH3) based on the specific enzyme deficiency involved.
What are the common synonyms and historical names for Primary Hyperoxaluria?
In medical literature, Primary Hyperoxaluria is sometimes referred to as primary hyperoxalosis or oxalate nephropathy, though the latter is often a descriptive term for the kidney damage caused by the disease rather than the genetic condition itself. Historically, because the condition leads to systemic crystal deposition, you may see it referenced as oxalosis or systemic oxalosis in older medical texts. These terms describe the end-stage consequence where oxalate deposits build up in tissues outside the kidneys, such as the bones, heart, and skin.
How is Primary Hyperoxaluria classified in medical systems?
Major medical databases use specific nomenclature to ensure clinical accuracy. In the Online Mendelian Inheritance in Man (OMIM) database, the three types are listed as follows:
- PH1 (Primary Hyperoxaluria Type 1): Caused by a deficiency of the AGT enzyme (OMIM #259900).
- PH2 (Primary Hyperoxaluria Type 2): Caused by a deficiency of the GRHPR enzyme (OMIM #260000).
- PH3 (Primary Hyperoxaluria Type 3): Caused by a deficiency of the HOGA1 enzyme (OMIM #613616).
Orphanet classifies Primary Hyperoxaluria under the umbrella of metabolic liver diseases, as the enzyme defects occur primarily in the liver, leading to systemic oxalate overload.
Why are there multiple names for this condition?
The variety of names for Primary Hyperoxaluria exists because the condition was historically identified by its symptoms—specifically kidney stones (nephrolithiasis) and kidney failure (nephrocalcinosis)—before the underlying genetic causes were fully understood. As our molecular understanding of Primary Hyperoxaluria has evolved, the medical community has shifted from using general symptomatic names like "oxalosis" to the more precise, enzyme-specific Primary Hyperoxaluria nomenclature, which is now the standard for clinical diagnosis and treatment planning.
Next steps
- Consult with a metabolic specialist or a nephrologist specializing in rare stone-forming diseases.
- Request genetic testing to confirm which specific type of Primary Hyperoxaluria you or your family member has.
- Join the DiseaseMaps.org community to connect with other patients and caregivers navigating this diagnosis.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Primary Hyperoxaluria
- Orphanet: Rare Disease Database (ORPHA:416)
- OMIM (Online Mendelian Inheritance in Man): Clinical Synopses for PH1, PH2, and PH3
- Oxalosis & Hyperoxaluria Foundation (OHF)
